BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18676410)

  • 21. Oxygen toxicity in premature infants.
    Weinberger B; Laskin DL; Heck DE; Laskin JD
    Toxicol Appl Pharmacol; 2002 May; 181(1):60-7. PubMed ID: 12030843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia.
    Paananen R; Husa AK; Vuolteenaho R; Herva R; Kaukola T; Hallman M
    J Pediatr; 2009 Jan; 154(1):39-43.e3. PubMed ID: 18760808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung injury and bronchopulmonary dysplasia in newborn infants.
    Christou H; Brodsky D
    J Intensive Care Med; 2005; 20(2):76-87. PubMed ID: 15855220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary β-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants.
    Shima Y; Nishimaki S; Nakajima M; Kumasaka S; Migita M
    J Perinatol; 2011 May; 31(5):330-4. PubMed ID: 21127468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitions and diagnostic criteria for bronchopulmonary dysplasia.
    Bancalari E; Claure N
    Semin Perinatol; 2006 Aug; 30(4):164-70. PubMed ID: 16860155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the use of 50% oxygen at birth in preterm infants reduce lung injury?
    Harling AE; Beresford MW; Vince GS; Bates M; Yoxall CW
    Arch Dis Child Fetal Neonatal Ed; 2005 Sep; 90(5):F401-5. PubMed ID: 15863491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis and prevention of chronic lung disease in the neonate.
    Askin DF; Diehl-Jones W
    Crit Care Nurs Clin North Am; 2009 Mar; 21(1):11-25, v. PubMed ID: 19237040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature newborns.
    Concolino P; Capoluongo E; Santonocito C; Vento G; Tana M; Romagnoli C; Zuppi C; Ameglio F; Brancaccio A; Sciandra F
    Clin Chim Acta; 2007 Mar; 378(1-2):164-7. PubMed ID: 17196572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in bronchopulmonary dysplasia.
    Bhandari A; Bhandari V
    Paediatr Respir Rev; 2013 Sep; 14(3):173-9. PubMed ID: 23523392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence?
    Thomas W; Speer CP
    Neonatology; 2008; 94(3):150-9. PubMed ID: 18679037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation.
    Bose C; Laughon M; Allred EN; Van Marter LJ; O'Shea TM; Ehrenkranz RA; Fichorova R; Leviton A;
    Pediatr Res; 2011 Apr; 69(4):347-53. PubMed ID: 21150694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for magnesium deficiency in the pathogenesis of bronchopulmonary dysplasia (BPD).
    Caddell JL
    Magnes Res; 1996 Oct; 9(3):205-16. PubMed ID: 9140865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ureaplasma and bronchopulmonary dysplasia.
    Gancia P; Delogu A; Pomero G
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S39-41. PubMed ID: 24709455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD?
    Asikainen TM; White CW
    Toxicol Appl Pharmacol; 2005 Mar; 203(2):177-88. PubMed ID: 15710178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants.
    Zhou D; Shi F; Xiong Y; Zhou M; Wan H; Liu H
    Eur J Pediatr; 2019 Jan; 178(1):81-87. PubMed ID: 30324231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchopulmonary dysplasia.
    Deakins KM
    Respir Care; 2009 Sep; 54(9):1252-62. PubMed ID: 19712501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New clinical entity in perinatology: fetal inflammatory response syndrome].
    Erdei G; Tóth P; Vásárhelyi B
    Orv Hetil; 2003 Aug; 144(31):1515-9. PubMed ID: 14502865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perinatal inflammation and infection.
    Cornette L
    Minerva Ginecol; 2005 Aug; 57(4):411-21. PubMed ID: 16170286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of renal inflammation: therapeutic strategies.
    Karkar A
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):1-19. PubMed ID: 18087117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.